India’s First Research Lens into the Heart of Cardiac Practice
Cath labs aren’t just treatment hubs, they’re decision theatres. Every day, across India, interventional cardiologists make rapid, high-stakes clinical decisions based on patient risk, real-world outcomes, procedural realities, and evolving therapeutic preferences. These are unfiltered, on-ground insights but until now, most pharma companies have had no structured way to access them.
Enter CathsEye™, a first-of-its-kind research product from WhiteSpace Consulting & Capability Building, designed to decode the pulse of India’s cath labs.
What is CathsEye™?
CathsEye™ is a proprietary research offering built to capture real-world, in-practice insights from interventional cardiologists across India. Our field teams and research frameworks are tailored to gather:
- Procedural preferences
- Therapeutic choices pre- and post-PCI
- Device-drug interplay trends
- Unmet needs and gaps in support
- Evolving mindsets in the cath lab ecosystem
Each CathsEye™ Report can be subscribed to as a syndicated tracker or commissioned as a custom study.
Why cath labs hold untapped strategic value?
- Clinical real-time decisions: Cath labs offer a direct lens into how therapy choices play out not just what guidelines suggest
Data blind spots: Most pharma teams rely on audit data, KOL panels, and outdated secondary reports not real intervention-site feedback
Growing cardiometabolic burden: With heart disease and diabetes overlapping, pharma brands in cardiometabolic portfolios need sharper insight than ever before.
Yet, despite their strategic relevance, Cath labs remain under-researched, under-reported, and under-leveraged.
Who’s using CathsEye™ and why?
Several of our pharma clients with high-stakes portfolios in cardiovascular and metabolic care have already subscribed to customised CathsEye Reports using our findings to:
- Validate brand positioning
- Uncover barriers to adoption
- Refine their HCP engagement strategy
- Develop sharper, more evidence-aligned messaging
Why WhiteSpace?
As pioneers in healthcare-focused primary research, we understand both the clinical nuance and commercial need. With CathsEye™, we’ve created a bridge between cath lab realities and boardroom decisions.
Want to know what India’s cath labs are really thinking? Look through the CathsEye™.